MedPath

CANESTEN COMBI-PAK 1 DAY THERAPY

CANESTEN COMBI-PAK 1 DAY THERAPY

Discontinued
DIN Number

02130238

Drug Class

Human

Market Date

Dec 31, 1994

Company
HC

miles canada inc. - consumer health care division

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02130238
AIG Number0219813001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
G01AF02 CLOTRIMAZOLE
Product Specifications
Dosage FormSuppository ,  Cream
Route of AdministrationVaginal ,  Topical
AHFS Classification84:04.08.08
Health Canada Classification

ACTIVE INGREDIENTS (2)

CLOTRIMAZOLEActive
Strength: 500 MG / KIT
Monograph: CLOTRIMAZOLE
CLOTRIMAZOLEActive
Strength: 1 % / KIT
Monograph: CLOTRIMAZOLE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.